17-Year-Old Non-Hodgkin’s Lymphoma Survivor Making a Difference

In a recent report by Oak Lawn Patch, Gina Bascio, a 17-year-old survivor of non-Hodgkin’s lymphoma was profiled. After her timely battle with cancer, this inspirational figure in the community made it a point to raise money in an effort to help other kids fight cancer.

After a January 2010 scoliosis test, Tabascio was diagnosed with stage 3 non-Hodgkin’s lymphoma. While the diagnosis scared her and her family, she maintained a fighting spirit that ultimately helped her make it through the five months of subsequent treatments. These treatments, of course, included chemotherapy and extended stints at the hospital.

Then, once she was informed that her cancer had gone into remission, the young hero figured that she wanted to use her experiences to help educate, and assist other kids and teens facing similar problems.

"She wanted to give back, she wants to find a cure and help other kids," her mother, Karen Tabascio, told Patch.

With the help of her mother, Gina put together a fundraiser for CureSearch, a non-profit group that helps fund research for youngsters who are fighting cancer. Taking their lead from the 17-year-old survivor, many community groups and leaders stepped in an effort to help her on her mission.

"I don’t mind talking about it and I feel that if it is going to help somebody else or make them want to do something to help," Tabascio said. "Every little bit helps find a cure."

Recent figures released by the American Cancer Society noted that approximately 66,120 people in America were diagnosed with non-Hodgkin’s lymphoma in 2008.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap